COVID-19 Humic/Fulvic Acid Plus Epigallocatechin Gallate Treatment: A Retrospective Chart Review

DOI record: { "DOI": "10.7759/cureus.77188", "ISSN": [ "2168-8184" ], "URL": "http://dx.doi.org/10.7759/cureus.77188", "author": [ { "affiliation": [], "family": "Williams", "given": "Richard", "sequence": "first" } ], "container-title": "Cureus", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2025, 1, 9 ] ], "date-time": "2025-01-09T15:05:02Z", "timestamp": 1736435102000 }, "deposited": { "date-parts": [ [ 2025, 1, 9 ] ], "date-time": "2025-01-09T15:05:11Z", "timestamp": 1736435111000 }, "indexed": { "date-parts": [ [ 2025, 1, 10 ] ], "date-time": "2025-01-10T05:24:48Z", "timestamp": 1736486688331, "version": "3.32.0" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 1, 9 ] ] }, "language": "en", "link": [ { "URL": "https://www.cureus.com/articles/308203-covid-19-humicfulvic-acid-plus-epigallocatechin-gallate-treatment-a-retrospective-chart-review", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "prefix": "10.7759", "published": { "date-parts": [ [ 2025, 1, 9 ] ] }, "published-print": { "date-parts": [ [ 2025, 1, 9 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "ref1", "unstructured": "The COVID tracking project. Accessed. October 11, 2023: https://covidtracking.com/.." }, { "DOI": "10.1016/j.compbiomed.2020.104137", "article-title": "A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2", "author": "Mhatre S", "doi-asserted-by": "publisher", "journal-title": "Comput Biol Med", "key": "ref2", "unstructured": "Mhatre S, Naik S, Patravale V. A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2. Comput Biol Med. 2021, 129:104137. 10.1016/j.compbiomed.2020.104137", "volume": "129", "year": "2021" }, { "DOI": "10.3390/foods11050694", "article-title": "In vitro determination of inhibitory effects of humic substances complexing Zn and Se on SARS-CoV-2 virus replication", "author": "Hajdrik P", "doi-asserted-by": "publisher", "journal-title": "Foods", "key": "ref3", "unstructured": "Hajdrik P, Pályi B, Kis Z, et al.. In vitro determination of inhibitory effects of humic substances complexing Zn and Se on SARS-CoV-2 virus replication. Foods. 2022, 11:694. 10.3390/foods11050694", "volume": "11", "year": "2022" }, { "DOI": "10.47587/SA.2020.1202", "article-title": "Humic substances as an environmental- friendly organic wastes potentially help as natural anti-virus to inhibit COVID-19", "author": "Hafez M", "doi-asserted-by": "publisher", "journal-title": "SA", "key": "ref4", "unstructured": "Hafez M, Popov AI, Zelenkov VN, et al.. Humic substances as an environmental- friendly organic wastes potentially help as natural anti-virus to inhibit COVID-19. SA. 2020, 1:53-60. 10.47587/SA.2020.1202", "volume": "1", "year": "2020" }, { "DOI": "10.1023/b:ifla.0000039563.90066.5d", "article-title": "An in vitro investigation of the anti-inflammatory properties of potassium humate", "author": "Jooné GK", "doi-asserted-by": "publisher", "journal-title": "Inflammation", "key": "ref5", "unstructured": "Jooné GK, van Rensburg CE. An in vitro investigation of the anti-inflammatory properties of potassium humate. Inflammation. 2004, 28:169-74. 10.1023/b:ifla.0000039563.90066.5d", "volume": "28", "year": "2004" }, { "DOI": "10.1016/j.phytochem.2006.06.020", "article-title": "Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives", "author": "Nagle DG", "doi-asserted-by": "publisher", "journal-title": "Phytochemistry", "key": "ref6", "unstructured": "Nagle DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry. 2006, 67:1849-55. 10.1016/j.phytochem.2006.06.020", "volume": "67", "year": "2006" }, { "key": "ref7", "unstructured": "Vitamin C. Accessed. October 30, 2024: https://ods.od.nih.gov/factsheets/VitaminC-HealthProfessional/.." }, { "DOI": "10.1016/j.foodchem.2020.127639", "article-title": "Dual effects of ascorbic acid on the stability of EGCG by the oxidation product dehydroascorbic acid promoting the oxidation and inhibiting the hydrolysis pathway", "author": "Chen L", "doi-asserted-by": "publisher", "journal-title": "Food Chem", "key": "ref8", "unstructured": "Chen L, Wang W, Zhang J, Cui H, Ni D, Jiang H. Dual effects of ascorbic acid on the stability of EGCG by the oxidation product dehydroascorbic acid promoting the oxidation and inhibiting the hydrolysis pathway. Food Chem. 2021, 337:127639. 10.1016/j.foodchem.2020.127639", "volume": "337", "year": "2021" }, { "DOI": "10.1093/cid/ciaa478", "article-title": "Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19", "author": "Bhimraj A", "doi-asserted-by": "publisher", "journal-title": "Clin Infect Dis", "key": "ref9", "unstructured": "Bhimraj A, Morgan RL, Shumaker AH, et al.. Infectious Diseases Society of America Guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020, 78: e83-e102. 10.1093/cid/ciaa478", "volume": "78", "year": "2020" }, { "key": "ref10", "unstructured": "COVID-19 prognostic tool. Accessed. November 28, 2024: https://reference.medscape.com/calculator/731/covid-19-prognostic-tool.." }, { "DOI": "10.1371/journal.pone.0237419", "article-title": "Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19", "author": "Jehi L", "doi-asserted-by": "publisher", "journal-title": "PLoS One", "key": "ref11", "unstructured": "Jehi L, Ji X, Milinovich A, et al.. Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19. PLoS One. 2020, 15:e0237419. 10.1371/journal.pone.0237419", "volume": "15", "year": "2020" }, { "DOI": "10.1038/s41591-020-01191-8", "article-title": "Individual and community-level risk for COVID-19 mortality in the United States", "author": "Jin J", "doi-asserted-by": "publisher", "journal-title": "Nat Med", "key": "ref12", "unstructured": "Jin J, Agarwala N, Kundu P, Harvey B, Zhang Y, Wallace E, Chatterjee N. Individual and community-level risk for COVID-19 mortality in the United States. Nat Med. 2021, 27:264-9. 10.1038/s41591-020-01191-8", "volume": "27", "year": "2021" }, { "DOI": "10.1155/2019/7090534", "article-title": "Role of Nrf2 and its activators in respiratory diseases", "author": "Liu Q", "doi-asserted-by": "publisher", "journal-title": "Oxid Med Cell Longev", "key": "ref13", "unstructured": "Liu Q, Gao Y, Ci X. Role of Nrf2 and its activators in respiratory diseases. Oxid Med Cell Longev. 2019, 2019:7090534. 10.1155/2019/7090534", "volume": "2019", "year": "2019" }, { "DOI": "10.1038/s41598-022-17088-0", "article-title": "The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor", "author": "LeBlanc EV", "doi-asserted-by": "publisher", "journal-title": "Sci Rep", "key": "ref14", "unstructured": "LeBlanc EV, Colpitts CC. The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor. Sci Rep. 2022, 12:12899. 10.1038/s41598-022-17088-0", "volume": "12", "year": "2022" }, { "DOI": "10.3390/molecules26195951", "article-title": "Catechins: therapeutic perspectives in COVID-19-associated acute kidney injury", "author": "Diniz LR", "doi-asserted-by": "publisher", "journal-title": "Molecules", "key": "ref15", "unstructured": "Diniz LR, Elshabrawy HA, Souza MT, Duarte AB, Datta S, de Sousa DP. Catechins: therapeutic perspectives in COVID-19-associated acute kidney injury. Molecules. 2021, 26:5951. 10.3390/molecules26195951", "volume": "26", "year": "2021" }, { "DOI": "10.1186/s13578-021-00680-8", "article-title": "Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor", "author": "Liu J", "doi-asserted-by": "publisher", "journal-title": "Cell Biosci", "key": "ref16", "unstructured": "Liu J, Bodnar BH, Meng F, et al.. Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor. Cell Biosci. 2021, 11:168. 10.1186/s13578-021-00680-8", "volume": "11", "year": "2021" }, { "DOI": "10.1016/j.isci.2020.101642", "article-title": "Furin: a potential therapeutic target for COVID-19", "author": "Wu C", "doi-asserted-by": "publisher", "journal-title": "iScience", "key": "ref17", "unstructured": "Wu C, Zheng M, Yang Y, et al.. Furin: a potential therapeutic target for COVID-19. iScience. 2020, 23:101642. 10.1016/j.isci.2020.101642", "volume": "23", "year": "2020" }, { "DOI": "10.1016/j.bbrc.2021.02.016", "article-title": "EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro", "author": "Jang M", "doi-asserted-by": "publisher", "journal-title": "Biochem Biophys Res Commun", "key": "ref18", "unstructured": "Jang M, Park R, Park YI, Cha YE, Yamamoto A, Lee JI, Park J. EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro. Biochem Biophys Res Commun. 2021, 547:23-8. 10.1016/j.bbrc.2021.02.016", "volume": "547", "year": "2021" }, { "DOI": "10.1016/j.jbc.2021.100306", "article-title": "SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis", "author": "Bayati A", "doi-asserted-by": "publisher", "journal-title": "J Biol Chem", "key": "ref19", "unstructured": "Bayati A, Kumar R, Francis V, McPherson PS. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J Biol Chem. 2021, 296:100306. 10.1016/j.jbc.2021.100306", "volume": "296", "year": "2021" }, { "DOI": "10.1093/carcin/bgn128", "article-title": "(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells", "author": "Adachi S", "doi-asserted-by": "publisher", "journal-title": "Carcinogenesis", "key": "ref20", "unstructured": "Adachi S, Nagao T, To S, et al.. (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis. 2008, 29:1986-93. 10.1093/carcin/bgn128", "volume": "29", "year": "2008" }, { "DOI": "10.1016/j.antiviral.2014.09.009", "article-title": "(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes", "author": "Huang HC", "doi-asserted-by": "publisher", "journal-title": "Antiviral Res", "key": "ref21", "unstructured": "Huang HC, Tao MH, Hung TM, Chen JC, Lin ZJ, Huang C. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. Antiviral Res. 2014, 111:100-11. 10.1016/j.antiviral.2014.09.009", "volume": "111", "year": "2014" }, { "DOI": "10.3389/fimmu.2021.769088", "article-title": "Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant", "author": "Cheong Y", "doi-asserted-by": "crossref", "journal-title": "Front Immunol", "key": "ref22", "unstructured": "Cheong Y, Kim M, Ahn J, et al.. Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant. Front Immunol. 2021, 12:769088.", "volume": "12", "year": "2021" }, { "DOI": "10.3390/ijms21145171", "article-title": "Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?", "author": "Menegazzi M", "doi-asserted-by": "publisher", "journal-title": "Int J Mol Sci", "key": "ref23", "unstructured": "Menegazzi M, Campagnari R, Bertoldi M, Crupi R, Di Paola R, Cuzzocrea S. Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?. Int J Mol Sci. 2020, 21:5171. 10.3390/ijms21145171", "volume": "21", "year": "2020" }, { "DOI": "10.1016/j.tips.2020.07.003", "article-title": "Can activation of NRF2 be a strategy against COVID-19?", "author": "Cuadrado A", "doi-asserted-by": "publisher", "journal-title": "Trends Pharmacol Sci", "key": "ref24", "unstructured": "Cuadrado A, Pajares M, Benito C, et al.. Can activation of NRF2 be a strategy against COVID-19?. Trends Pharmacol Sci. 2020, 41:598-610. 10.1016/j.tips.2020.07.003", "volume": "41", "year": "2020" }, { "DOI": "10.1016/j.phyplu.2022.100402", "article-title": "Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: major interactions with host/virus proteases", "author": "Dinda B", "doi-asserted-by": "publisher", "journal-title": "Phytomed Plus", "key": "ref25", "unstructured": "Dinda B, Dinda S, Dinda M. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-O-gallate (EGCG) in SARS-CoV-2 infection: major interactions with host/virus proteases. Phytomed Plus. 2023, 3:100402. 10.1016/j.phyplu.2022.100402", "volume": "3", "year": "2023" }, { "article-title": "Potassium humate reduces inflammation and clinically improves the outcomes of patients with osteoarthritis of the knee", "author": "Van Rensburg CE", "journal-title": "Open Conf Proc J", "key": "ref26", "unstructured": "Van Rensburg CE, Badenhorst BE, Gandy JJ, et al.. Potassium humate reduces inflammation and clinically improves the outcomes of patients with osteoarthritis of the knee. Open Conf Proc J. 2010, 1:", "volume": "1", "year": "2010" }, { "DOI": "10.1007/s705-002-8319-5", "article-title": "In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid", "author": "Lu FJ", "doi-asserted-by": "publisher", "journal-title": "Arch Virol", "key": "ref27", "unstructured": "Lu FJ, Tseng SN, Li ML, Shih SR. In vitro anti-influenza virus activity of synthetic humate analogues derived from protocatechuic acid. Arch Virol. 2002, 147:273-84. 10.1007/s705-002-8319-5", "volume": "147", "year": "2002" }, { "DOI": "10.3390/molecules26133962", "article-title": "Antiviral effects of green tea EGCG and its potential application against COVID-19", "author": "Wang YQ", "doi-asserted-by": "publisher", "journal-title": "Molecules", "key": "ref28", "unstructured": "Wang YQ, Li QS, Zheng XQ, Lu JL, Liang YR. Antiviral effects of green tea EGCG and its potential application against COVID-19. Molecules. 2021, 26:3962. 10.3390/molecules26133962", "volume": "26", "year": "2021" }, { "DOI": "10.1111/1440-1681.12428", "article-title": "Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling", "author": "Sriram N", "doi-asserted-by": "publisher", "journal-title": "Clin Exp Pharmacol Physiol", "key": "ref29", "unstructured": "Sriram N, Kalayarasan S, Manikandan R, Arumugam M, Sudhandiran G. Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling. Clin Exp Pharmacol Physiol. 2015, 42:849-59. 10.1111/1440-1681.12428", "volume": "42", "year": "2015" }, { "DOI": "10.1155/2022/6606423", "article-title": "Humic acids inhibit platelet activation to reduce venous thromboembolism in mice", "author": "Lan HT", "doi-asserted-by": "publisher", "journal-title": "Evid Based Complement Alternat Med", "key": "ref30", "unstructured": "Lan HT, Zheng YT, Tong ZJ, Zhang C, Cong XY, Wang ZH. Humic acids inhibit platelet activation to reduce venous thromboembolism in mice. Evid Based Complement Alternat Med. 2022, 2022:6606423. 10.1155/2022/6606423", "volume": "2022", "year": "2022" }, { "DOI": "10.1016/S0049-3848(99)00104-8", "article-title": "Antithrombotic activities of green tea catechins and (−)-epigallocatechin gallate", "author": "Kang WS", "doi-asserted-by": "publisher", "journal-title": "Thrombosis Research", "key": "ref31", "unstructured": "Kang WS, Lim IH, Yuk DY, et al.. Antithrombotic activities of green tea catechins and (−)-epigallocatechin gallate. Thrombosis Research. 1999, 96:229-37. 10.1016/S0049-3848(99)00104-8", "volume": "96", "year": "1999" }, { "DOI": "10.1002/ddr.10058", "article-title": "Medical drugs from humus matter: focus on mumie", "author": "Schepetkin I", "doi-asserted-by": "publisher", "journal-title": "Drug Development Research", "key": "ref32", "unstructured": "Schepetkin I, Khlebnikov A, Kwon BS. Medical drugs from humus matter: focus on mumie. Drug Development Research. 2002, 57:140-59. 10.1002/ddr.10058", "volume": "57", "year": "2002" }, { "DOI": "10.2147/DDDT.S314666", "article-title": "An overview on the potential roles of EGCG in the treatment of COVID-19 infection", "author": "Bimonte S", "doi-asserted-by": "publisher", "journal-title": "Drug Des Devel Ther", "key": "ref33", "unstructured": "Bimonte S, Forte CA, Cuomo M, Esposito G, Cascella M, Cuomo A. An overview on the potential roles of EGCG in the treatment of COVID-19 infection. Drug Des Devel Ther. 2021, 15:4447-54. 10.2147/DDDT.S314666", "volume": "15", "year": "2021" }, { "DOI": "10.1016/j.tifs.2021.05.023", "article-title": "Potential protective mechanisms of green tea polyphenol EGCG against COVID-19", "author": "Zhang Z", "doi-asserted-by": "publisher", "journal-title": "Trends Food Sci Technol", "key": "ref34", "unstructured": "Zhang Z, Zhang X, Bi K, He Y, Yan W, Yang CS, Zhang J. Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol. 2021, 114:11-24. 10.1016/j.tifs.2021.05.023", "volume": "114", "year": "2021" } ], "reference-count": 34, "references-count": 34, "relation": {}, "resource": { "primary": { "URL": "https://www.cureus.com/articles/308203-covid-19-humicfulvic-acid-plus-epigallocatechin-gallate-treatment-a-retrospective-chart-review" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "COVID-19 Humic/Fulvic Acid Plus Epigallocatechin Gallate Treatment: A Retrospective Chart Review", "type": "journal-article" }